Abcellera Biologics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABCL

Based on 3 analysts offering 12 month price targets for Abcellera Biologics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ABCL stock?

Based on 3 analysts offering ratings for Abcellera Biologics Inc.
Strong Buy
Strong Buy
3 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABCL stock forecasts and price targets.

ABCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color

1 of 1

ABCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$5.05$14.33+183.82%Strong Buy
FDMT$29.37$50.80+72.97%Strong Buy
SLNO$49.19$55.60+13.03%Strong Buy

Abcellera Biologics Stock Forecast FAQ

Is Abcellera Biologics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.

Out of 3 analysts, 3 (100%) are recommending ABCL as a Strong Buy, 0 (0%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.

What is ABCL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ABCL price target, the average ABCL price target is $14.33, with the highest ABCL stock price forecast at $20.00 and the lowest ABCL stock price forecast at $6.00.

On average, Wall Street analysts predict that Abcellera Biologics's share price could reach $14.33 by Feb 21, 2025. The average Abcellera Biologics stock price prediction forecasts a potential upside of 183.82% from the current ABCL share price of $5.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.